Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Morocco Update

26 Oct 2020 07:00

RNS Number : 1262D
Quadrise Fuels International PLC
26 October 2020
 

26 October 2020

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

COMPLETION OF MOROCCAN PILOT PLANT TRIAL

AND

NEW INDUSTRIAL SCALE TRIAL AT ANOTHER OF THE CLIENT'S SITES IN MOROCCO

 

Quadrise is pleased to provide an update on the Material Transfer & Cooperation Agreement (the "Agreement") with an international chemicals and mining group headquartered in Morocco (the "Client") announced on 29 November 2019.

 

Following the relaxation of Covid-19 restrictions, Quadrise was able to gain access to the Client's facility in October 2020 and is pleased to confirm that the pilot plant trial has now been completed by the combined Quadrise and Client project team.

 

Quadrise and the Client are now working jointly on detailed plans for a larger, industrial-scale MSAR® trial at another Client site, which is planned for early Q1 2021, ahead of the commercial scale phase 2 trials.

 

This new industrial-scale MSAR® trial is intended to further demonstrate the wider potential of MSAR® at another site ahead of the commercial scale trials already being planned under phase 2 of the Agreement. The study work for the Phase 2 trials was brought forward earlier this year and is now well advanced; and, together, with the new industrial scale trial further minimises the risk of delay to the overall programme.

 

Further updates will be provided, as appropriate, in due course.

Mike Kirk, Chairman of QFI, said:

"The major industrial group in Morocco we are working with is a world leader in the sectors in which it operates and is a material consumer of fuel oil. As such, we are delighted to have been able to successfully deliver the MSAR® pilot plant trial under very challenging circumstances which is a testament to the strong rapport and relationships we have built with the Client.

"Feasibility studies are simultaneously being completed under phase 2 as previously reported, that together with the planned industrial scale trials announced today, will demonstrate the wider potential for MSAR® use at the client's sites and more widely in the industrial sector.

"We are therefore confident that during 2021 we will successfully validate the economic and environmental benefits of MSAR® at an industrial scale, complete the commercial scale trials on the Client's units and initiate commercial supply of MSAR® after concluding commercial supply agreements."

 

For further information, please contact:

 

Quadrise Fuels International Plc

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

Joint Brokers

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

David McKeown

Shore Capital Stockbrokers Limited

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

 

Public & Investor Relations

FTI Consulting

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFSAIELEFII
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
29th Nov 20197:00 amRNSAGM Update
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.